Literature DB >> 14573695

Legionella pneumophila suppresses macrophage interleukin-12 production by activating the p42/44 mitogen-activated protein kinase cascade.

Kazuto Matsunaga1, Hiroyuki Yamaguchi, Thomas W Klein, Herman Friedman, Yoshimasa Yamamoto.   

Abstract

A possible involvement of the mitogen-activated protein (MAP) kinase cascade in the inhibition of macrophage interleukin-12 (IL-12) production by Legionella pneumophila infection was examined. The results of MAP kinase inhibition by p42/44 and p38 MAP kinase inhibitors and of p42/44 MAP kinase activity assays indicate that L. pneumophila infection of macrophages causes a selective inhibition of lipopolysaccharide-induced IL-12 production by activating the p42/44 MAP kinase cascade. In addition, it was also revealed that the p38 MAP kinase may be important for the production of IL-12 but not for the inhibition caused by L. pneumophila infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14573695      PMCID: PMC219421          DOI: 10.1128/IAI.71.11.6672-6675.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Interferon-gamma-activated human monocytes inhibit the intracellular multiplication of Legionella pneumophila.

Authors:  N Bhardwaj; T W Nash; M A Horwitz
Journal:  J Immunol       Date:  1986-10-15       Impact factor: 5.422

2.  Alveolar macrophage cell line MH-S is valuable as an in vitro model for Legionella pneumophila infection.

Authors:  K Matsunaga; T W Klein; H Friedman; Y Yamamoto
Journal:  Am J Respir Cell Mol Biol       Date:  2001-03       Impact factor: 6.914

3.  Extracellular signal-related kinase (ERK) and p38 mitogen-activated protein (MAP) kinases differentially regulate the lipopolysaccharide-mediated induction of inducible nitric oxide synthase and IL-12 in macrophages: Leishmania phosphoglycans subvert macrophage IL-12 production by targeting ERK MAP kinase.

Authors:  G J Feng; H S Goodridge; M M Harnett; X Q Wei; A V Nikolaev; A P Higson; F Y Liew
Journal:  J Immunol       Date:  1999-12-15       Impact factor: 5.422

4.  Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism.

Authors:  M Barral-Netto; A Barral; C E Brownell; Y A Skeiky; L R Ellingsworth; D R Twardzik; S G Reed
Journal:  Science       Date:  1992-07-24       Impact factor: 47.728

5.  Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages.

Authors:  C S Hsieh; S E Macatonia; C S Tripp; S F Wolf; A O'Garra; K M Murphy
Journal:  Science       Date:  1993-04-23       Impact factor: 47.728

6.  Potent suppression of IL-12 production from monocytes and dendritic cells during endotoxin tolerance.

Authors:  C L Karp; M Wysocka; X Ma; M Marovich; R E Factor; T Nutman; M Armant; L Wahl; P Cuomo; G Trinchieri
Journal:  Eur J Immunol       Date:  1998-10       Impact factor: 5.532

Review 7.  Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster.

Authors:  Martha Triantafilou; Kathy Triantafilou
Journal:  Trends Immunol       Date:  2002-06       Impact factor: 16.687

8.  IFN-gamma-activated human alveolar macrophages inhibit the intracellular multiplication of Legionella pneumophila.

Authors:  T W Nash; D M Libby; M A Horwitz
Journal:  J Immunol       Date:  1988-06-01       Impact factor: 5.422

9.  Legionella pneumophila-induced blastogenesis of murine lymphoid cells in vitro.

Authors:  H Friedman; R Widen; T Klein; L Searls; K Cabrian
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

10.  Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells.

Authors:  A D'Andrea; M Rengaraju; N M Valiante; J Chehimi; M Kubin; M Aste; S H Chan; M Kobayashi; D Young; E Nickbarg
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

View more
  8 in total

Review 1.  IL12Rβ1: the cytokine receptor that we used to know.

Authors:  Richard T Robinson
Journal:  Cytokine       Date:  2014-12-13       Impact factor: 3.861

2.  Legionella pneumophila evades gamma interferon-mediated growth suppression through interleukin-10 induction in bone marrow-derived macrophages.

Authors:  Sadako Yoshizawa; Kazuhiro Tateda; Tetsuya Matsumoto; Fumio Gondaira; Shuichi Miyazaki; Theodore J Standiford; Keizo Yamaguchi
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

3.  Macrophages from mice with the restrictive Lgn1 allele exhibit multifactorial resistance to Legionella pneumophila.

Authors:  Isabelle Derré; Ralph R Isberg
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

4.  CB(1) and CB(2) cannabinoid receptors mediate different aspects of delta-9-tetrahydrocannabinol (THC)-induced T helper cell shift following immune activation by Legionella pneumophila infection.

Authors:  Catherine A Newton; Ping-Jen Chou; Izabella Perkins; Thomas W Klein
Journal:  J Neuroimmune Pharmacol       Date:  2008-09-16       Impact factor: 4.147

5.  Transcriptional inhibition of interleukin-12 promoter activity in Leishmania spp.-infected macrophages.

Authors:  Asha Jayakumar; Robyn Widenmaier; Xiaojing Ma; Mary Ann McDowell
Journal:  J Parasitol       Date:  2008-02       Impact factor: 1.276

Review 6.  A new inflammatory cytokine on the block: re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17.

Authors:  S L Gaffen; G Hajishengallis
Journal:  J Dent Res       Date:  2008-09       Impact factor: 6.116

7.  Immune Control of Legionella Infection: An in vivo Perspective.

Authors:  Ralf Schuelein; Desmond K Y Ang; Ian R van Driel; Elizabeth L Hartland
Journal:  Front Microbiol       Date:  2011-06-03       Impact factor: 5.640

8.  Molecular characterization of Legionella pneumophila-induced interleukin-8 expression in T cells.

Authors:  Reika Takamatsu; Hiromitsu Teruya; Eriko Takeshima; Chie Ishikawa; Kunihiro Matsumoto; Naofumi Mukaida; Jian-Dong Li; Klaus Heuner; Futoshi Higa; Jiro Fujita; Naoki Mori
Journal:  BMC Microbiol       Date:  2010-01-05       Impact factor: 3.605

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.